SMC-THC is a licensed company specializing in the production of medical cannabis, backed by Portuguese and Swiss investors. Our primary focus is to enhance the cannabis industry by conducting extensive research and development using cutting-edge innovation and technology. This investment has enabled us to cultivate flowers with the highest concentration of THC, making them ideal for medical research in various sectors.

Since 2019, we have been committed to providing our partners with the highest quality flowers to develop medical products while actively participating in scientific advancements that showcase the medical benefits of cannabis. Our entire organizational structure adheres to the highest standards of compliance set by the sector and applicable legislation, including INFARMED. We pride ourselves on producing high-quality medical cannabis, cultivating exclusively in indoor growing rooms to ensure optimal growing conditions.

We strictly follow Good Manufacturing Practice (GMP) guidelines and continuously monitor our products in the laboratory. Leveraging advanced techniques and a team of qualified professionals, we guarantee a consistent profile of high THC and terpenes in our cannabis. At SMC-THC, we prioritize ecological responsibility, minimizing the impact of cannabis production on the environment.

We also uphold strict ethical standards in an expanding market, placing strong emphasis on control. As an independent brand, we are not dependent on any other group, allowing us to uphold and impose our own philosophy. Through strategic partnerships with leading research institutions and universities, we actively engage in research and development to create scientific knowledge and drive pharmaceutical innovation.

We hold authorization from INFARMED to cultivate, import, and export medicinal cannabis. For more information and updates, please contact us at info@smc-thc. com.

Thank you for your interest in SMC-THC – transforming the medical cannabis industry with uncompromising quality and innovation